Familial aggregation of renal disease in a population-based case- control study

Journal of the American Society of Nephrology

Volumn 9, Issue 7, 1998, Pages 1270-1276

  Lei, Hsien Hsien ^a   Perneger, Thomas V ^b   Klag, Michael J ^a,c,d   Whelton, Paul K ^e   Coresh, Josef ^a,c,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FAMILIAL DISEASE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SOCIOECONOMICS; STATISTICAL ANALYSIS;

EID: 0031798864     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. United States Renal Data System: USRDS 1997 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997
2. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995
3. Knebelmann B, Antignac C, Gubler NC, Grunfeld JP: A molecular approach to inherited kidney disorders. Kidney Int 44: 1205-1216, 1993
4. Somlo S, Wirth B, Germino GG, Weinstat-Saslow D, Gillespie GA, Himmelbauer H, Steevens L, Coucke P, Willems P, Bachner L, Coto E, Lopez-Larrea C, Peral B, San Millan JL, Saris JJ, Breuning MH, Frischauf A-M, Reeders ST: Fine genetic localization of the gene for autosomal dominant polycystic kidney disease (PKD1) with respect to physically mapped markers. Genomics 13: 152-158, 1992
5. Freedman BI, Tuttle AB, Spray BJ: Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 25: 710-713, 1995
6. Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 41: 1189-1196, 1988
7. Steenland NK, Thun MJ, Ferguson CW, Port FK: Occupational and other exposures associated with male end-stage renal disease: A case/control study. Am J Public Health 80: 153-157, 1990
8. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 21: 387-393, 1993
9. Spray BJ, Atassi NG, Tuttle AB, Freedman BI: Familial risk, age at onset, and cause of end-stage renal disease in white Americans. J Am Soc Nephrol 5: 1806-1810, 1995
10. Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 331: 1675-1679, 1994
11. Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121: 912-918, 1994
12. SAS Institute, Inc.: SAS Language: Reference, version 6, Cary, NC, SAS Institute, Inc., 1990
13. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
14. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722, 1992
15. Muldoon MF, Terrell DF, Bunker CH, Manuck SB: Family history studies in hypertension research: Review of the literature. Am J Hypertens 6: 76-88, 1993
16. Bergman SM, Key BO, Kirk KA, Warnok DG, Rostand SG: Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 3: 341-346, 1996
17. U.S. Bureau of the Census: General population characteristics, Chapter B. Part 10, District of Columbia; Part 22, Maryland; Part 48, Virginia; Part 50, West Virginia. In: 1980 Census of Population. Volume 1: Characteristics of the Population, Washington, DC, U.S. Government Printing Office, 1982
18. Perneger TV, Klag MJ, Whelton PK: Race and socioeconomic status in hypertension and renal disease. Curr Opin Nephrol Hypertens 4: 235-239, 1995
19. Perneger TV, Whelton PK, Klag MJ: Race and end-stage renal disease: Socioeconomic status and access to health care as mediating factors. Arch Intern Med 155: 1201-1208, 1995
20. Young EW, Mauger EA, Jiang KH, Port FK, Wolfe RA: Socioeconomic status and end-stage renal disease in the United States. Kidney Int 45: 907-911, 1994
21. Byrne C, Nedelman J, Luke RG: Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis 23: 16-22, 1994
22. Nuyts GD, Daelemans RA, Jorens PG, Elseviers MM, Van de Vyver FL, De Broe ME: Does lead play a role in the development of chronic renal disease? Nephrol Dial Transplant 6: 307-315, 1991
23. LeDuc JW, Childs JE, Glass GE: The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: A possible cause of hypertension and chronic renal disease in the United States. Annu Rev Public Health 13: 79-98, 1992
24. Warner GS: Hantavirus illness in humans: Review and update. South Med J 89: 264-271, 1996
25. Williams W: Poststreptococcal glomerulonephritis: How important is it as a cause of chronic renal diseases? Transplant Proc 19: 97-100, 1987
26. Dodge WF, Spargo BH, Bass JA, Travis LB: The relationship between the clinical and pathologic features of poststreptococcal glomerulonephritis: A study of the early natural history. Medicine (Baltimore) 47: 227-267, 1968
27. Freedman BI, Bowden DW: The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 4: 230-234, 1995
28. Schmidt A, Klener HP, Barnas U, Arias I, Illievich A, Auinger M, Graninger W, Kaider A, Mayer G: Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7: 314-317, 1996
29. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43: 690-695, 1994
30. Krolewski AS, Doria A, Magre J, Warram JH, Housman D: Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 3[Suppl]: S9-S17, 1992
31. Doria A, Warram JH, Rich SS, Krolewski AS: Angiotensin I-converting enzyme (ACE): Estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots. Hum Genet 94: 117-123, 1994
32. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494, 1995